[In Process Citation].

Klinik für Neurologie, Universitätsspital Zürich.
Praxis 12/2013; 102(25):1529-35. DOI: 10.1024/1661-8157/a001505
Source: PubMed


Parkinson's disease belongs to the most prevalent neurodegenerative disorders and manifests both with motor and non-motor symptoms. Symptomatic treatment of this disorder became more multifaceted over the past years: Besides classical dopaminergic drugs and physiotherapy, novel invasive escalation treatment strategies became gold standard in many countries. On the other hand, non-motor symptoms significantly impacts quality of life in many patients which necessitates initiation of adequate therapy.

2 Reads